M11.162 Familial chondrocalcinosis, left knee

Name of the Condition

• Familial chondrocalcinosis, left knee

Summary

Familial chondrocalcinosis, left knee is a hereditary condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the left knee joint and surrounding tissues. This leads to inflammation, pain, and potential joint damage. It is part of the broader group of crystal arthropathies and is distinguished by its familial inheritance pattern and left knee-specific involvement. Diagnosis typically involves clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, left knee is caused by genetic mutations that influence calcium pyrophosphate crystal formation in the left knee’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Family history of chondrocalcinosis or related crystal arthropathies.
• Advanced age (increases likelihood of crystal deposition).
• Metabolic conditions affecting calcium or phosphate levels.
• Left knee trauma or surgery (may trigger crystal release).
• Chronic inflammatory joint diseases.

Symptoms

• Left knee pain, swelling, and stiffness.
• Recurrent episodes of acute inflammation.
• Reduced range of motion in the left knee.
• Joint locking or instability.

Diagnosis

Diagnosis of familial chondrocalcinosis, left knee involves a combination of clinical assessment, imaging studies (e.g., X-rays, ultrasound, or MRI), and laboratory tests. Imaging may reveal characteristic crystal deposits or joint changes. Joint fluid analysis can confirm CPPD crystals, though this is not always required. Family history and genetic testing may support the diagnosis.

Treatment Options

• Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation.
• Corticosteroid injections for acute flare-ups.
• Colchicine for recurrent episodes.
• Physical therapy to maintain joint function.
• Surgical intervention (e.g., arthroscopy) for severe cases with joint damage.

Prognosis and Follow-Up

Prognosis varies depending on the extent of joint damage and response to treatment. Early diagnosis and management can help control symptoms and slow progression. Regular follow-up with a healthcare provider is recommended to monitor joint health and adjust treatment as needed.

Complications

• Chronic joint pain and stiffness.
• Progressive joint damage or osteoarthritis.
• Recurrent acute attacks.
• Reduced mobility or disability.

Lifestyle & Prevention

• Maintain a healthy weight to reduce joint stress.
• Avoid activities that strain the left knee.
• Use assistive devices (e.g., braces) if needed.
• Follow a balanced diet to support joint health.

When to Seek Professional Help

Seek medical attention if you experience persistent left knee pain, swelling, or stiffness, or if symptoms worsen despite home care. Acute episodes with severe pain or inability to bear weight require prompt evaluation.

Tips for Medical Coders

Document the specific site (left knee) and familial nature of the condition. Ensure clinical documentation supports the diagnosis, including details of joint involvement and family history. Verify that the code M11.162 is used for left knee-specific familial chondrocalcinosis, distinguishing it from unspecified or bilateral cases.